Skip to main content
logo
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.750
-0.070 (-3.85%)
At close: May 15, 2026, 4:00 PM EDT
1.780
+0.030 (1.71%)
After-hours: May 15, 2026, 7:56 PM EDT

Gain Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
7513559533765
Market Cap Growth
26.20%131.17%10.59%42.48%-42.36%-
Enterprise Value
60.06115.1548.636.8817.9928.93
Last Close Price
1.753.222.163.273.135.43
PE Ratio
--5.28-2.43-1.91-2.11-3.96
PS Ratio
---960.42265.47391.09
PB Ratio
5.407.307.984.211.971.85
P/TBV Ratio
4.545.726.733.381.971.59
P/FCF Ratio
--7.34-3.10-2.81-2.51-5.18
P/OCF Ratio
--7.34-3.11-2.81-2.53-5.22
EV/Sales Ratio
---668.36128.43175.35
EV/EBITDA Ratio
--6.19-2.40-1.66-1.02-2.09
EV/EBIT Ratio
--6.15-2.39-1.66-1.01-2.09
EV/FCF Ratio
--6.24-2.57-1.95-1.21-2.32
Debt / Equity Ratio
0.030.030.050.050.050.04
Debt / EBITDA Ratio
-0.03-0.04-0.03-0.05-0.07-0.12
Debt / FCF Ratio
-0.04-0.04-0.04-0.05-0.09-0.13
Net Debt / Equity Ratio
-1.13-1.08-1.33-1.25-1.00-1.01
Net Debt / EBITDA Ratio
0.811.080.480.711.072.55
Net Debt / FCF Ratio
0.821.090.520.841.272.83
Asset Turnover
-000.000.000.01
Quick Ratio
4.266.222.663.394.8814.45
Current Ratio
4.696.632.973.595.1114.78
Return on Equity (ROE)
-130.42%-155.66%-204.95%-141.57%-65.52%-67.73%
Return on Assets (ROA)
-99.19%-111.87%-136.01%-104.58%-56.66%-56.93%
Return on Invested Capital (ROIC)
-2241.26%-2006.64%-3246.71%-1578.04%-921.53%-1026.79%
Return on Capital Employed (ROCE)
-114.78%-135.20%-186.09%-132.33%-63.03%-62.96%
Earnings Yield
-27.97%-18.94%-41.20%-52.29%-47.28%-25.23%
FCF Yield
-25.51%-13.63%-32.24%-35.63%-39.82%-19.31%
Buyback Yield / Dilution
-42.24%-44.08%-75.86%-9.49%-16.90%-279.11%
Total Shareholder Return
-42.24%-44.08%-75.86%-9.49%-16.90%-279.11%
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q